Insights

The era of easy arbitrage is over. If you have spent the last three years running a 503B outsourcing facility, […]

The Crucible of Market Dominance: A Paradigm Shift In pharmaceutical and biotechnology innovation patent litigation is not a mere legal

The rules of pharmaceutical competition in Europe are no longer a matter of simple patent filing and clinical success. By

The pharmaceutical industry operates at the confluence of high-stakes molecular innovation and rigorous intellectual property fortification. Among the most sophisticated

The pharmaceutical supply chain remains a largely invisible mechanism until the moment it ceases to function. Much like a Victorian

Pharmaceutical companies treat time as their most expensive commodity. In an industry where a patent clock starts ticking long before

The pharmaceutical industry, by its very nature, is a landscape defined by cycles of innovation and competition. For decades, the

The Boundary Between Pharmacy Practice and Unapproved Manufacturing The pharmaceutical industry currently stands at a critical inflection point where the

The pharmaceutical industry operates on a paradox. A company spends a decade and $2.6 billion to invent a single molecule,